Clinical Study

FORTIGEL® – Bioactive Collagen Peptides, scientifically proven to regenerate joint cartilage

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by Gelita AG , and any views and opinions expressed do not necessarily reflect those of

Gelita AG

Against the backdrop of age-related health concerns, physical mobility is one of the most vital determiners of quality of life. Made up of optimized collagen peptides, FORTIGEL®​ has been scientifically proven to stimulate measurable synthesis of cartilage tissue. Thus, it treats the actual cause of joint problems rather than just the symptoms. With more than 25 per cent of the population suffering from joint problems, orally applied FORTIGEL®​ is an important therapeutic opportunity, for those suffering from pain, instability, weakness and a reduced range of motion.

Related resources from Gelita AG

Show more

Supplier info centre